10x Genomics (TXG) R&D In Process (2018 - 2020)
10x Genomics recorded quarterly R&D In Process of $406.9 million in Q4 2020, up 901.33% quarter-over-quarter from $40.6 million in Q3 2020.
10x Genomics' R&D In Process history runs 2 years deep, the most recent figure standing at $406.9 million for Q4 2020.
- In Q4 2020, R&D In Process changed N/A year-over-year to $406.9 million; the TTM figure through Dec 2021 stood at $447.5 million (changed 0.0% YoY), while the FY2020 annual figure was $447.5 million, changed N/A from the prior year.
- R&D In Process came in at $406.9 million for Q4 2020 at 10x Genomics, up from $40.6 million in the prior quarter.
- In the past five years, R&D In Process ranged from a high of $406.9 million in Q4 2020 to a low of $16.1 million in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D In Process (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Teladoc Health | 1.42 Bn | 672.39 Mn | 562.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 406.91 Mn |
| Sep 30, 2020 | 40.64 Mn |
| Dec 31, 2018 | 40.05 Mn |
| Sep 30, 2018 | 16.10 Mn |